- 专利标题: Blood glucose regulation through control of breathing
-
申请号: US12920535申请日: 2009-03-05
-
公开(公告)号: US09827389B2公开(公告)日: 2017-11-28
- 发明人: Steven Paul Farrugia
- 申请人: Steven Paul Farrugia
- 申请人地址: AU
- 专利权人: ResMed Limited
- 当前专利权人: ResMed Limited
- 当前专利权人地址: AU
- 代理机构: Lerner, David, Littenberg, Krumholz & Mentlik, LLP
- 国际申请: PCT/AU2009/000271 WO 20090305
- 国际公布: WO2009/109013 WO 20090911
- 主分类号: A61M16/00
- IPC分类号: A61M16/00 ; A61B5/145 ; A61B5/00 ; G06F19/00
摘要:
A respiratory treatment apparatus (1) provides blood glucose monitoring and breathing control based on detected blood glucose information. In an example embodiment, a flow generator provides a flow of breathable gas at a pressure above atmospheric to a patient interface according to a pressure treatment control protocol such as a CPAP, APAP, bi-level CPAP, etc. A detector determines a blood glucose condition indicator with one or more sensors that are used to sense physiological information. In response to signals from the sensors, a controller, such as a digital signal processor, controls adjustments to the flow of breathable gas provided by the flow generator. The adjustments are determined by the controller based on the detected blood glucose indicator and/or changes thereto.
公开/授权文献
- US20110132370A1 BLOOD GLUCOSE REGULATION THROUGH CONTROL OF BREATHING 公开/授权日:2011-06-09
信息查询
IPC分类: